News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Merck & Co., Inc. Extends Deadline For Talks On Dutch Organon Closures
December 17, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AMSTERDAM Dec 17 (Reuters) - U.S. drugmaker Merck & Co Inc (MRK.N) said on Friday it has further postponed the closure of some of its Dutch operations pending discussions about possible alternatives, including a sale of the R&D site.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
Europe
Merck & Co.
MORE ON THIS TOPIC
Earnings
J&J Aims for $100B in Sales, Puts Stelara Patent Cliff ‘in the Rearview Mirror’
January 21, 2026
·
2 min read
·
Dan Samorodnitsky
Podcast
JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return
January 21, 2026
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
GSK Picks Up RAPT for $2.2B as Miels Makes First Move as CEO
January 20, 2026
·
2 min read
·
Tristan Manalac
Job Trends
BioSpace
Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs
January 20, 2026
·
2 min read
·
Chantal Dresner
